TP53 mutation prevalence in normal airway epithelium as a biomarker for lung cancer risk. Craig DJ, Crawford EL, Chen H, Grogan EL, et al. BMC Cancer 2023;23:783.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Craig DJ, Crawford EL, Chen H, Grogan EL, et al. TP53 mutation prevalence in normal airway epithelium as a biomarker for lung cancer risk. BMC Cancer 2023;23:783.
PMID: 37612638